TEACHING FACULTY
Dr. Yang LU is the Center Medical Director of Clinical Nuclear Medicine in the Department of Nuclear Medicine at the University of Texas MD Anderson Cancer Center (MDACC). He is also the Immediate Past President of the American College of Nuclear Medicine. Dr. Lu has over 100 peer-reviewed publications, served as PI and Co-I on a number of NIH, industry, society and charity funded projects, and received many prestigious awards including the ones from SNMMI, ACNM, and National Organization of Rare Disorders. His initiative work on using FDG PET/CT for cardiac sarcoidosis has been well recognized and cited, including the prestigious award from the Bernie Mac Foundation for Sarcoidosis.
Prior to joining MDACC Dr. Lu served as Chief of Section of Nuclear Medicine and PET/CT in the University of Illinois Hospital & Health Sciences System from 2011-2017 after finishing nuclear medicine residency and nuclear oncology training at Memorial Sloan Kettering Cancer Center in New York. As an MD PhD graduate from a foreign medical school, the Second Military Medical University in Shanghai, China, Dr. Lu first came to the US as a postdoctoral researcher in Albert Einstein College of Medicine. His extensive clinical and research training in both China and the US contributed to his achievement so far.
Prior to joining MDACC Dr. Lu served as Chief of Section of Nuclear Medicine and PET/CT in the University of Illinois Hospital & Health Sciences System from 2011-2017 after finishing nuclear medicine residency and nuclear oncology training at Memorial Sloan Kettering Cancer Center in New York. As an MD PhD graduate from a foreign medical school, the Second Military Medical University in Shanghai, China, Dr. Lu first came to the US as a postdoctoral researcher in Albert Einstein College of Medicine. His extensive clinical and research training in both China and the US contributed to his achievement so far.